SOST and periodontal disorder: Considering the above biological effects of sclerostin, the present study investigated whether GCF sclerostin levels could be used as a biomarker of periodontal disease activity in patients with Stage III Grade C generalized periodontitis (SIII-GC) and Stage III Grade B generalized periodontitis (SIII-GB).